(Q30817169)

26 June 2017

1 reference

title

Virus-like particles: a new family of delivery systems (English)

1 reference

26 June 2017

Florence Boisgérault

1

1 reference

26 June 2017

Gabriel Morón

series ordinal

2

1 reference

26 June 2017

Claude Leclerc

series ordinal

3

1 reference

26 June 2017

publication date

1 June 2002

1 reference

Expert Review of Vaccines

26 June 2017

published in

1 reference

26 June 2017

volume

1

1 reference

26 June 2017

issue

1

1 reference

26 June 2017

page(s)

101-109

1 reference

Human papillomavirus vaccines

26 June 2017

cites work

1 reference

https://api.crossref.org/works/10.1586%2F14760584.1.1.101

Papillomavirus L1 major capsid protein self-assembles into virus-like particles that are highly immunogenic

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.1.1.101

Systemic immunization with papillomavirus L1 protein completely prevents the development of viral mucosal papillomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.1.1.101

Recombinant Norwalk virus-like particles given orally to volunteers: phase I study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.1.1.101

A poliovirus neutralization epitope expressed on hybrid hepatitis B surface antigen particles

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.1.1.101

Epitopes of the human malaria parasite P. falciparum carried on the surface of HBsAg particles elicit an immune response against the parasite

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.1.1.101

Induction of single and dual cytotoxic T-lymphocyte responses to viral proteins in mice using recombinant hybrid Ty-virus-like particles

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.1.1.101

A recombinant virus-like particle system derived from parvovirus as an efficient antigen carrier to elicit a polarized Th1 immune response without adjuvant

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.1.1.101

Effect of different baculovirus inactivation procedures on the integrity and immunogenicity of porcine parvovirus-like particles.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.1.1.101

Papillomavirus virus-like particles can deliver defined CTL epitopes to the MHC class I pathway.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.1.1.101

Papillomavirus virus-like particles for the delivery of multiple cytotoxic T cell epitopes

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.1.1.101

Hybrid papillomavirus L1 molecules assemble into virus-like particles that reconstitute conformational epitopes and induce neutralizing antibodies to distinct HPV types

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.1.1.101

Mucosal immunisation with papillomavirus virus-like particles elicits systemic and mucosal immunity in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.1.1.101

Induction of mucosal and systemic immunity to a recombinant simian immunodeficiency viral protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.1.1.101

Dendritic cells acquire antigen from apoptotic cells and induce class I-restricted CTLs

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.1.1.101

Cross-presentation in viral immunity and self-tolerance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.1.1.101

Cross-presentation, dendritic cells, tolerance and immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.1.1.101

Alternative pathways for processing exogenous and endogenous antigens that can generate peptides for MHC class I-restricted presentation

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.1.1.101

Dendritic cells pulsed with exogenous hepatitis B surface antigen particles efficiently present epitopes to MHC class I-restricted cytotoxic T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.1.1.101

Physical interaction of human papillomavirus virus-like particles with immune cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.1.1.101

Effect of preexisting neutralizing antibodies on the anti-tumor immune response induced by chimeric human papillomavirus virus-like particle vaccines.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.1.1.101

21 January 2018

Identifiers

DOI

10.1586/14760584.1.1.101

1 reference

26 June 2017

1 reference